CME Group (NASDAQ:CME) Releases Earnings Results

CME Group (NASDAQ:CME) issued its earnings results on Wednesday. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03, Briefing.com reports. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.25 earnings per share.

CME Group Stock Performance

Shares of CME opened at $226.14 on Friday. CME Group has a 52-week low of $190.70 and a 52-week high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a 50-day moving average price of $218.57 and a 200 day moving average price of $208.81. The firm has a market capitalization of $81.43 billion, a PE ratio of 25.73, a P/E/G ratio of 7.76 and a beta of 0.55.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.03%. CME Group’s dividend payout ratio is presently 52.33%.

Insider Transactions at CME Group

In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. TD Cowen assumed coverage on shares of CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 target price on the stock. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Oppenheimer upped their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday. The Goldman Sachs Group upped their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $222.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.